Delivery Order SPE2DR25D2206-SPE2DR26F9FF0
- Not listed
- The Defense Logistics Agency awarded a $2,800.35 delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Meropenem 0.9% Sodium Chloride 1 Gram/50s, an antibiotic medication used in military and federal healthcare systems. This competitively awarded, firm fixed-price delivery order, with an ultimate completion date of November 13, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $7,161.56 delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Meropenem 0.9% Sodium Chloride 1 gram/50s, an antibiotic pharmaceutical product. This firm fixed-price contract, which is not set-aside, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $7,365.36 to AmerisourceBergen Drug Corp for the supply of Meropenem 0.9% Sodium Chloride 1 Gram/50s, a broad-spectrum antibiotic used in military and federal healthcare settings. The award, issued on August 14, 2025, with completion targeted for August 15, 2025, utilizes firm fixed pricing under a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the performance...
- The Defense Logistics Agency awarded a delivery order valued at $10,310.23 to AmerisourceBergen Drug Corp for the supply of Meropenem 0.9% Sodium Chloride 1 gram/50s, an antibiotic medication used in military and federal healthcare systems. This competitively awarded, firm fixed-price delivery order has an ultimate completion date of September 22, 2025, and is being performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. No set-aside designation was applied to this...
- The Defense Logistics Agency awarded a $1,434.58 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Meropenem 0.9% Sodium Chloride 1 Gram/50 units. This competitively awarded, firm fixed-price contract is set to be completed by August 11, 2025, with performance taking place at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The contract represents a child delivery order issued under a larger vehicle, consistent with AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,668.21 on June 16, 2025, for the supply of Meropenem 0.9% Sodium Chloride 1 gram/50 units. This firm fixed price contract, which was not set-aside, is set for completion by June 17, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of pharmaceutical support services through the company's existing contract vehicle...
- The Defense Logistics Agency awarded a delivery order valued at $1,172.48 to AmerisourceBergen Drug Corp for the supply of Meropenem 2 gram vials, with an ultimate completion date of September 5, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its pharmaceutical distribution operations...
- The Defense Logistics Agency awarded a delivery order valued at $2,928.76 to AmerisourceBergen Drug Corp on April 29, 2025, for the supply of Meropenem 0.9% Saline solution (1 gram/50s) with performance completion by April 30, 2025. This competitive, non-set-aside award utilizes a firm fixed price structure and represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply agreement. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,317.62 to AmerisourceBergen Drug Corp for the supply of Meropenem 2 gram vials, an antibiotic pharmaceutical product. The contract was awarded on August 21, 2025, with an ultimate completion date of August 22, 2025, using firm fixed price terms without any set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office...
- This delivery order, valued at $3,055.46, was awarded to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Meropenem 0.9% Sodium Chloride (1 gram/50 milliliters) to support federal medical procurement needs. The contract employs firm fixed pricing and carries an ultimate completion date of August 15, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for the federal government's military and...
- SPE2DR25D2206Indefinite Delivery Contract
- SPE2DR25D2206-SPE2DR26F9FF0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $11,537.13 to AmerisourceBergen Drug Corp for the supply of Meropenem 0.9% Sodium Chloride 1 Gram/50s, a broad-spectrum antibiotic used in military and federal healthcare systems. This firm fixed price, non-set-aside contract was awarded on December 10, 2025, with an ultimate completion date of December 11, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement executed through established federal contracting mechanisms. This delivery order operates as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen, a major pharmaceutical distributor and critical federal medical vendor, has demonstrated substantial capability in fulfilling diverse pharmaceutical procurement requirements across the Defense Health System. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply medications, vaccines, medical devices, and specialized healthcare commodities to military healthcare programs and other federal agencies worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.5k | 12/9/25 |